18 May – 21 May 2019 in MELBOURNE CONVENTION AND EXHIBITION CENTRE, MELBOURNE, VICTORIA, AUSTRALIA
The role of interleukin-1β in pydoerma gangrenosum and the novel off label use of probenicid to target this cytokine
Continued treatment with secukinumab is associated with high retention or regain of response
Secukinumab is superior to ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: CLARITY, a randomized, controlled, phase 3b trial
A chlorhexidine conundrum: Chlorhexidine hypersensitivity reactions and burns
A review of cutaneous lupus erythematosus treatment
Dermal burns sustained through thermal therapy for presumed lyme disease
Hypercalcaemia in non-melanoma skin cancer: A case report and systematic review of the literature
More unsightly than striae: Complications due to use of topical agents with microneedling
Omalizumab (xolair) in treatment resistant bullous pemphigoid
The unexpected consequences of climate change and globalization on tick populations: An Australian perspective
Allergic contact dermatitis to alcohol swabs masquerading as a tape allergy
Long-term psoriasis control following secukinumab discontinuation indicates disease modification of moderate to severe psoriasis: Clinical and mechanistic results
Pentoxifylline as a treatment for granuloma annulare
A case series of 13 patients with oestrogen hypersensitivity vulvitis treated with cyproterone acetate
Treatment of chronic telogen effluvium with oral minoxidil
Widespread acneiform eruption in a young child secondary to histone deactylase inhibitor
2021 Dermcoll, 53RD ANNUAL SCIENTIFIC MEETING, THE ART OF DERMATOLOGY
2019 Dermcoll, 52ND ANNUAL SCIENTIFIC MEETING